Nithya Ramnath

6.7k total citations · 1 hit paper
123 papers, 4.1k citations indexed

About

Nithya Ramnath is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Nithya Ramnath has authored 123 papers receiving a total of 4.1k indexed citations (citations by other indexed papers that have themselves been cited), including 60 papers in Oncology, 57 papers in Pulmonary and Respiratory Medicine and 40 papers in Molecular Biology. Recurrent topics in Nithya Ramnath's work include Lung Cancer Treatments and Mutations (39 papers), Lung Cancer Diagnosis and Treatment (31 papers) and Lung Cancer Research Studies (21 papers). Nithya Ramnath is often cited by papers focused on Lung Cancer Treatments and Mutations (39 papers), Lung Cancer Diagnosis and Treatment (31 papers) and Lung Cancer Research Studies (21 papers). Nithya Ramnath collaborates with scholars based in United States, China and Australia. Nithya Ramnath's co-authors include Frank Weinberg, Deepak Nagrath, Everett E. Vokes, David G. Beer, Michael J. Kelley, Dongfeng Tan, Patrick J. Creaven, Paul N. Bogner, Douglas A. Arenberg and Guoan Chen and has published in prestigious journals such as New England Journal of Medicine, Journal of Biological Chemistry and Journal of Clinical Oncology.

In The Last Decade

Nithya Ramnath

118 papers receiving 4.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Reactive Oxygen Species in the Tumor Microenvironment: An Overview

2019 355 citations Frank Weinberg, Nithya Ramnath et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Nithya Ramnath United States	33	1.7k	1.5k	1.4k	666	431	123	4.1k
Jing Gao China	36	1.4k 0.8×	1.9k 1.3×	1.7k 1.2×	1.1k 1.6×	430 1.0×	240	4.6k
Luboš Petruželka Czechia	31	1.6k 1.0×	2.0k 1.3×	872 0.6×	771 1.2×	280 0.6×	181	3.8k
Kimihiro Shimizu Japan	37	2.1k 1.3×	1.6k 1.1×	1.7k 1.2×	674 1.0×	650 1.5×	256	4.8k
Caimiao Wei United States	29	1.1k 0.7×	1.4k 1.0×	971 0.7×	727 1.1×	216 0.5×	61	3.5k
Mansoor M. Ahmed United States	35	1.1k 0.7×	985 0.7×	1.1k 0.8×	454 0.7×	862 2.0×	116	3.5k
Petr Kavan Canada	29	1.1k 0.7×	1.5k 1.0×	1.0k 0.7×	876 1.3×	417 1.0×	141	4.4k
Qinghua Zhou China	29	1.7k 1.0×	1.5k 1.0×	1.2k 0.9×	926 1.4×	277 0.6×	215	3.8k
Nagio Takigawa Japan	41	2.9k 1.8×	2.9k 1.9×	1.9k 1.4×	749 1.1×	287 0.7×	304	5.2k
Michael L. Cher United States	42	2.5k 1.5×	2.0k 1.3×	1.9k 1.3×	1.6k 2.4×	437 1.0×	165	5.5k
Tomomi Kamba Japan	27	1.2k 0.7×	1.0k 0.7×	1.3k 1.0×	635 1.0×	262 0.6×	152	3.3k

Countries citing papers authored by Nithya Ramnath

Since Specialization

Citations

This map shows the geographic impact of Nithya Ramnath's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nithya Ramnath with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nithya Ramnath more than expected).

Fields of papers citing papers by Nithya Ramnath

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nithya Ramnath. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nithya Ramnath. The network helps show where Nithya Ramnath may publish in the future.

Co-authorship network of co-authors of Nithya Ramnath

This figure shows the co-authorship network connecting the top 25 collaborators of Nithya Ramnath. A scholar is included among the top collaborators of Nithya Ramnath based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nithya Ramnath. Nithya Ramnath is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Bryant, Alex K., Yuewei Lin, James M. Rae, et al.. (2024). Artificial intelligence to unlock real‐world evidence in clinical oncology: A primer on recent advances. Cancer Medicine. 13(12). e7253–e7253. 4 indexed citations

Zhou, Katherine I., et al.. (2023). P2.09-15 Real World Efficacy and Safety of Sotorasib in U.S. Veterans with KRAS G12C Mutated Non-Small Cell Lung Cancer. Journal of Thoracic Oncology. 18(11). S337–S338. 1 indexed citations

Malhotra, Binu, Shirish M. Gadgeel, Bryan J. Schneider, et al.. (2023). A Phase II Trial of Pevonedistat and Docetaxel in Patients With Previously Treated Advanced Non–Small-Cell Lung Cancer. Clinical Lung Cancer. 25(2). 128–134. 7 indexed citations

Reddy, Rishindra M., Kiran H. Lagisetty, Jules Lin, et al.. (2023). Comprehensive sampling of the lung microbiome in early-stage non–small cell lung cancer. JTCVS Open. 17. 260–268. 3 indexed citations

Edwards, Donna M., K. Nathan Sankar, Matthew J. Schipper, et al.. (2023). Pneumonitis After Chemoradiotherapy and Adjuvant Durvalumab in Stage III Non-Small Cell Lung Cancer. International Journal of Radiation Oncology*Biology*Physics. 118(4). 963–970. 8 indexed citations

Taxbro, Knut, Jennifer Horowitz, Qisu Zhang, et al.. (2022). Patterns of use and outcomes of peripherally inserted central catheters in hospitalized patients with solid tumors: A multicenter study. Cancer. 128(20). 3681–3690. 15 indexed citations

Bryant, Alex K., K. Nathan Sankar, Lili Zhao, et al.. (2022). De-escalating adjuvant durvalumab treatment duration in stage III non-small cell lung cancer. European Journal of Cancer. 171. 55–63. 17 indexed citations

Bryant, Alex K., K. Nathan Sankar, Garth W. Strohbehn, et al.. (2021). Prognostic and predictive value of neutrophil-to-lymphocyte ratio with adjuvant immunotherapy in stage III non-small-cell lung cancer. Lung Cancer. 163. 35–41. 22 indexed citations

Schaefer, Jordan K. & Nithya Ramnath. (2020). Fluorouracil-Induced Hyperpigmentation. New England Journal of Medicine. 382(4). e6–e6.

10.

Huang, Wei, Paramita Ray, Wenbin Ji, et al.. (2020). The cytochrome P450 enzyme CYP24A1 increases proliferation of mutant KRAS-dependent lung adenocarcinoma independent of its catalytic activity. Journal of Biological Chemistry. 295(18). 5906–5917. 6 indexed citations

11.

Kong, Feng‐Ming, Randall K. Ten Haken, Matthew J. Schipper, et al.. (2017). Effect of Midtreatment PET/CT-Adapted Radiation Therapy With Concurrent Chemotherapy in Patients With Locally Advanced Non–Small-Cell Lung Cancer. PMC. 9 indexed citations

12.

Shiratsuchi, Hiroe, Zhuwen Wang, Guoan Chen, et al.. (2016). Oncogenic Potential of CYP24A1 in Lung Adenocarcinoma. Journal of Thoracic Oncology. 12(2). 269–280. 29 indexed citations

13.

Nadal, Ernest, Anna Truini, Asuka Nakata, et al.. (2015). A Novel Serum 4-microRNA Signature for Lung Cancer Detection. Scientific Reports. 5(1). 12464–12464. 108 indexed citations

14.

Nadal, Ernest, Jinjie Zhong, Jules Lin, et al.. (2014). A MicroRNA Cluster at 14q32 Drives Aggressive Lung Adenocarcinoma. Clinical Cancer Research. 20(12). 3107–3117. 85 indexed citations

15.

Schneider, Bryan J., Shirish M. Gadgeel, Nithya Ramnath, et al.. (2011). Phase II Trial of Sunitinib Maintenance Therapy After Platinum-Based Chemotherapy in Patients with Extensive-Stage Small Cell Lung Cancer. Journal of Thoracic Oncology. 6(6). 1117–1120. 25 indexed citations

16.

Chen, Guoan, Sinae Kim, Jeremy M. G. Taylor, et al.. (2011). Development and Validation of a Quantitative Real-Time Polymerase Chain Reaction Classifier for Lung Cancer Prognosis. Journal of Thoracic Oncology. 6(9). 1481–1487. 21 indexed citations

17.

Chen, Guoan, So Hee Kim, Amanda N. King, et al.. (2010). CYP24A1 Is an Independent Prognostic Marker of Survival in Patients with Lung Adenocarcinoma. Clinical Cancer Research. 17(4). 817–826. 85 indexed citations

18.

King, Amanda N., David G. Beer, Paul J. Christensen, Robert U. Simpson, & Nithya Ramnath. (2010). The Vitamin D/CYP24A1 Story in Cancer. Anti-Cancer Agents in Medicinal Chemistry. 10(3). 213–224. 51 indexed citations

19.

Zhang, Suyi, Mariela Blum Murphy, Jun Yang, et al.. (2006). Quality Assurance. Modern Pathology. 19. 320–324. 1 indexed citations

20.

Deeb, George, Jianmin Wang, Nithya Ramnath, et al.. (2004). Altered E-cadherin and epidermal growth factor receptor expressions are associated with patient survival in lung cancer: a study utilizing high-density tissue microarray and immunohistochemistry. Modern Pathology. 17(4). 430–439. 62 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact